- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Omkar Herlekar, Promoter of Lasa Supergenerics Limited, has provided an annual disclosure indicating that there has been no encumbrance of shares either directly or indirectly during the financial year ended March 31, 2025, apart from what has been previously reported. This transparency reinforces the company's governance and management integrity, potentially enhancing shareholder trust. The lack of share encumbrance may foster a positive outlook among investors, reflecting stability in the promoter's stake and overall company performance.